[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346179-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346179-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","polygenic-risk-scores-and-plasma-proteomics-identify-cancer-related-proteins-graphical-abstract-and-highlights","Polygenic risk scores and plasma proteomics identify cancer-related proteins - graphical abstract and highlights","","Integration of cancer polygenic risk scores (PRSs) with plasma proteomics prioritizes cancer-related proteins and trans-regulated protein-network components. Using 4,955 plasma proteins from cancer-free ARIC participants across 21 cancers, pQTS links PRS signals to individual circulating protein levels, while ARCHIE partitions risk variants into interpretable trans-regulated protein networks via sparse canonical correlation analysis. Results include 90 protein associations (including 53 distal trans associations) and 19 network components spanning 433 proteins, connecting to driver genes, somatic alterations, immune cell populations, CRISPR dependencies, and cancer-relevant pathways.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/polygenic-risk-scores-and-plasma-proteomics-identify-cancer-related-proteins-graphical-abstract-and-highlights/346179/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/polygenic-risk-scores-and-plasma-proteomics-identify-cancer-related-proteins-graphical-abstract-and-highlights/346179.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the core goal of integrating PRS with plasma proteomics?","Question",{"text":63,"@type":64},"To prioritize cancer-related proteins and trans-regulated protein-network components by connecting inherited susceptibility signals to measurable circulating proteins.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does pQTS differ from ARCHIE in the analysis?",{"text":68,"@type":64},"pQTS tests associations between cancer PRS and individual protein levels, whereas ARCHIE partitions risk variants into interpretable trans-regulated protein-network components using sparse canonical correlation analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"What scale of findings are reported across the 21 cancers?",{"text":72,"@type":64},"pQTS identifies 90 protein associations, including 53 distal trans associations, and ARCHIE identifies 19 components spanning 433 proteins.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346179,1790193110,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":26,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Short article  \nPolygenic risk scores and plasma proteomics identify cancer-related proteins and trans-regulated protein networks  \nGraphical abstract  \nHighlights  \n• Cancer PRS-proteome analyses identify trans-regulated proteins across 21 cancers  \nAuthors  \nDiptavo Dutta, Jingning Zhang, Xinyu Guo, ..., Alexis J. Battle, Elizabeth A. Platz, Nilanjan Chatterjee  \nCorrespondence  \n[diptavo.dutta@nih.gov](diptavo.dutta@nih.gov) (D.D.),  \n[nchatte2@jhu.edu](nchatte2@jhu.edu) (N.C.)  \nIn brief  \nDutta et al. integrate cancer polygenic risk scores with plasma proteomics across 21 cancers to identify transregulated proteins associated with germline susceptibility variants using two complementary approaches. pQTS detects individual PRS-protein associations, whereas ARCHIE partitions risk variants into interpretable protein networks, with cervical cancer and basal cell carcinoma as examples.  \n• PQTS links cancer risk scores to individual circulating protein levels  \n• ARCHIE partitions cancer risk variants into interpretable protein networks  \n• Examples of how distinct subnetworks and pathways are encoded within cancer PRSs  \nDutta et al., 2026, Cell Genomics 6, 101322 September 9, 2026 Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xgen.2026.101322](https://doi.org/10.1016/j.xgen.2026.101322)  \nll  \nll  \nOPEN ACCESS  \nShort article  \nPolygenic risk scores and plasma proteomics identify cancer-related proteins  \nand trans-regulated protein networks  \nDiptavo Dutta,1,10,11,* Jingning Zhang,2,10 Xinyu Guo,3 Rosamund Quint,2 Mary R. Rooney,4,5 Mitchell J. Machiela,1 Kevin M. Brown,6 Josef Coresh,2,4,7 Alexis J. Battle,8 Elizabeth A. Platz,4,9 and Nilanjan Chatterjee2,9,*  \n1Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20850, USA  \n2Department of Biostatistics, Johns Hopkins University, Baltimore, MD 21205, USA  \n3Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA 90089, USA  \n4Department of Epidemiology, Johns Hopkins University, Baltimore, MD 21205, USA  \n5Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD 21205, USA  \n6Laboratory of Translational Genetics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20850, USA  \n7Optimal Aging Institute, Department of Population Health, New York University Grossman School of Medicine, New York, NY 10003, USA  \n8Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA  \n9Department of Oncology, Johns Hopkins University School of Medicine, and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21205, USA  \n10These authors contributed equally  \n11Lead contact  \n*Correspondence: [diptavo.dutta@nih.gov](diptavo.dutta@nih.gov) (D. D.), [nchatte2@jhu.edu](nchatte2@jhu.edu) (N.C.) [https://doi.org/10.1016/j.xgen.2026.101322](https://doi.org/10.1016/j.xgen.2026.101322)  \nSUMMARY  \nGenome-wide association studies identify cancer susceptibility loci, but downstream protein mechanisms remain incompletely defined. We integrate polygenic risk scores (PRSs) for 21 cancers with 4,955 plasma proteins measured in cancer-free Atherosclerosis Risk in Communities (ARIC) participants to prioritize cancer-related proteins and protein networks. The protein quantitative trait score (pQTS) approach assesses associations between cancer PRS and individual protein levels, while ARCHIE partitions cancer risk variants into trans-regulated protein-network components using sparse canonical correlation analysis. Across cancers, pQTS identifies 90 protein associations, including 53 distal trans associations, and ARCHIE identifies 19 components spanning 433 proteins. Downstream analyses connect prioritized proteins to cancer driver genes, somatic alterations, immune cell populations, CRISPR dependency, and cancer-relevant pathways. Cervic","cbCaiuannqnzaVqW","https://ap.wps.com/l/cbCaiuannqnzaVqW","pdf",3091429,17,"English","# Summary\n# Methods overview\n## pQTS approach\n## ARCHIE approach\n# Key results across 21 cancers\n## Protein associations and trans-regulated networks\n# Downstream biological analyses\n# Example cancer mechanisms","[{\"question\":\"What is the core goal of integrating PRS with plasma proteomics?\",\"answer\":\"To prioritize cancer-related proteins and trans-regulated protein-network components by connecting inherited susceptibility signals to measurable circulating proteins.\"},{\"question\":\"How does pQTS differ from ARCHIE in the analysis?\",\"answer\":\"pQTS tests associations between cancer PRS and individual protein levels, whereas ARCHIE partitions risk variants into interpretable trans-regulated protein-network components using sparse canonical correlation analysis.\"},{\"question\":\"What scale of findings are reported across the 21 cancers?\",\"answer\":\"pQTS identifies 90 protein associations, including 53 distal trans associations, and ARCHIE identifies 19 components spanning 433 proteins.\"}]","Polygenic risk scores and plasma proteomics identify cancer-related proteins - graphical abstract and highlights | PDF",1790060402,43,[147,151],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/99b7175b4aa1fc78f2a32af3dfabf755.webp",983,1276,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/9bddbbf7b9f8398455b0c702cf7d5670.webp",982,1275]